China will strive for the listing of chemicals in Europe and America
Penicillin manufactured in China is exported in the form of penicillin industrial salt. After deep processing in India, it can enter the European and American markets as pharmaceuticals. In order to change this embarrassing situation, the National Development and Reform Commission proposed that during the “11th Five-Year Plan†period, it strives for five chemical drug preparations to qualify for listing in the United States or the European Union and enter the international mainstream pharmaceutical market.
The "Development and Reform Commission" publicized this month the "Eleventh Five-Year Development Guidance Opinion for the Pharmaceutical Industry" published in May. Although China's export of chemical raw materials is relatively large, there are not many products registered and certified through the international market, and most products still use chemical products. Product forms enter the international market.
According to this guideline, "the establishment of a pharmaceutical industry with strong international competitiveness, some fields entering the world's leading ranks, and laying a solid foundation for the transition to a powerful pharmaceutical country" has become one of the major goals of China's "Eleventh Five-Year Plan" pharmaceutical industry development.
In the field of chemical raw material medicine, China will realize the industrialization of 20 products with high market growth potential and high added value through the innovation of technology, technology and equipment, and form a new competitive advantage in the international market; a number of products have passed international registration and are truly Enter the international market. In the field of TCM products, develop and market 20 to 30 modern TCM products with perfect quality standards, clear efficacy mechanism, safety, efficiency, stability, and controllability; strive for 10 to 10 in the fields of major, acute infectious diseases and chronic severe diseases. Fifteen innovative drugs and new vaccines with proprietary intellectual property rights in China have been industrialized and put on the market.
At the same time, China will add 10 to 20 kinds of digitalized, non-invasive or minimally invasive diagnostic and therapeutic equipment and industrialization of medical materials, so that the level of technical performance and quality of domestic medical device products will be greatly improved, and will be able to better meet basic requirements. Medical services are the mainstay of multi-level clinical needs.
The "Development and Reform Commission" publicized this month the "Eleventh Five-Year Development Guidance Opinion for the Pharmaceutical Industry" published in May. Although China's export of chemical raw materials is relatively large, there are not many products registered and certified through the international market, and most products still use chemical products. Product forms enter the international market.
According to this guideline, "the establishment of a pharmaceutical industry with strong international competitiveness, some fields entering the world's leading ranks, and laying a solid foundation for the transition to a powerful pharmaceutical country" has become one of the major goals of China's "Eleventh Five-Year Plan" pharmaceutical industry development.
In the field of chemical raw material medicine, China will realize the industrialization of 20 products with high market growth potential and high added value through the innovation of technology, technology and equipment, and form a new competitive advantage in the international market; a number of products have passed international registration and are truly Enter the international market. In the field of TCM products, develop and market 20 to 30 modern TCM products with perfect quality standards, clear efficacy mechanism, safety, efficiency, stability, and controllability; strive for 10 to 10 in the fields of major, acute infectious diseases and chronic severe diseases. Fifteen innovative drugs and new vaccines with proprietary intellectual property rights in China have been industrialized and put on the market.
At the same time, China will add 10 to 20 kinds of digitalized, non-invasive or minimally invasive diagnostic and therapeutic equipment and industrialization of medical materials, so that the level of technical performance and quality of domestic medical device products will be greatly improved, and will be able to better meet basic requirements. Medical services are the mainstay of multi-level clinical needs.
concrete mixing pump ,concrete mixer pump,concrete mixer with pump
Zhengzhou XinFeng machinery manufacturing Co. Ltd , https://www.xfmachinery.com